Vulva cancer
MONDO:0001528A primary or metastatic malignant neoplasm involving the vulva.
Also known as: neoplasm of vulva, vulval neoplasm, vulvar tumour, cancer of mammalian vulva, malignant mammalian vulva neoplasm, malignant neoplasm of mammalian vulva, malignant neoplasm of the vulva, malignant neoplasm of vulva
2934 clinical trials for this condition and its sub-types, 88 tagged with Vulva cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Vulva cancer
-
Vulvar carcinoma 24 trials · 45 incl. sub-types
9 sub-types
- Vulvar squamous cell carcinoma 22 trials Sub-types →
- Vulvar adenocarcinoma 3 trials · 5 incl. sub-types Sub-types →
- Bartholin gland carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Clitoral carcinoma 0 trials
- Labia majora carcinoma 0 trials
- Labia minora carcinoma 0 trials
- Vulva basal cell carcinoma 0 trials
- Vulvar neuroendocrine carcinoma 0 trials Sub-types →
- Vulvar seborrheic keratosis 0 trials Sub-types →
-
Vulvar melanoma 3 trials
-
Clitoris cancer 0 trials
1 sub-type
- Clitoral carcinoma 0 trials
-
Labia minora cancer 0 trials
1 sub-type
- Labia minora carcinoma 0 trials
-
Labium majus cancer 0 trials
1 sub-type
- Labia majora carcinoma 0 trials
-
Mixed germ cell tumor of vulva 0 trials
-
Paraurethral gland cancer 0 trials
1 sub-type
- Adenocarcinoma of skene gland origin 0 trials
-
Vulva sarcoma 0 trials
5 sub-types
- Vulvar alveolar soft part sarcoma 0 trials
- Vulvar childhood botryoid-type embryonal rhabdomyosarcoma 0 trials
- Vulvar leiomyosarcoma 0 trials
- Vulvar liposarcoma 0 trials
- Vulvar proximal-type epithelioid sarcoma 0 trials
Most studied deeper sub-types
-
New HPV vaccine combo aims to fight Hard-to-Treat cancers
Disease control CompletedThis study tests an HPV vaccine (PRGN-2009) alone or with a drug called M7824 in people with HPV-positive cancers like cervical, anal, and throat cancers. The goal is to find a safe dose and see if the combination boosts the immune system's attack on tumors. The trial includes 39…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Triple immunotherapy attack shows promise against Hard-to-Treat HPV cancers
Disease control CompletedThis study tests a combination of three immunotherapy drugs—PDS0101, M7824, and NHS-IL12—in people with advanced HPV-related cancers such as cervical, anal, and throat cancers. The goal is to see if the mix can shrink tumors or stop them from growing. Participants receive the dru…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered immune cells take on HPV cancers
Disease control CompletedThis trial tested a new therapy for cancers caused by HPV-16, such as cervical, anal, and throat cancers. Researchers took patients' white blood cells, genetically engineered them to recognize a protein called E7 found in HPV cancer cells, and infused them back. Patients also rec…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
A simple dye might replace radioactive tracers in cancer staging
Diagnosis CompletedThis trial tests whether indocyanine green, a dye injected before surgery, can find sentinel lymph nodes as reliably as the standard technetium-99 radioactive tracer. About 744 adults with various cancers will receive both agents, and surgeons will compare detection rates using a…
Phase 3 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Blood test may catch pelvic cancer relapse sooner
Diagnosis CompletedThis study looks at whether a blood test that detects tumor DNA can find early signs of cancer returning in people treated for HPV-positive pelvic cancers (like cervical or anal cancer). Researchers will take blood samples from 172 patients during regular follow-up visits. The go…
Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Cancer Survivors' sex drive gets a boost: bupropion shows promise
Symptom relief CompletedThis study tested whether bupropion, a medication that affects brain chemicals, can improve low sexual desire in women who have had breast or gynecologic cancer. About 230 women took either bupropion or a placebo pill for 9 weeks. The main goal was to see if their self-reported s…
Phase 2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Can a nurse and an app improve life after gynecologic cancer?
Symptom relief CompletedThis study tested a new way to follow up with gynecologic cancer survivors. Instead of seeing a doctor every time, patients saw a nurse at every other visit and used a smartphone app to help manage their health. The goal was to see if this approach improved self-management skills…
Sponsor: Sorlandet Hospital HF • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Can brain training ease 'Chemo Brain' in gynecologic cancer survivors?
Symptom relief CompletedThis study tested a home-based cognitive training program called BrainHQ in 60 women with gynecologic cancers who had memory or thinking problems after chemotherapy. Participants used the app for about 2.5 hours per week for 10 weeks. The goal was to see if the program was practi…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can pelvic PT help cancer survivors regain sexual health?
Symptom relief CompletedThis study looked at whether a 10-week pelvic physical therapy program is practical for gynecologic cancer survivors who have sexual problems. Twenty survivors were enrolled to see if they could stick with the program and if it improved their sexual function and quality of life. …
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Simple leg position change may reduce radiation burns in vulvar cancer
Symptom relief CompletedThis study tested whether lying with legs straight or bent (frog-leg) during radiation therapy for vulvar cancer affects skin burns. Twenty women with early-stage vulvar cancer took part. The goal was to see which position causes fewer skin side effects and whether it shortens tr…
Sponsor: King Hussein Cancer Center • Aim: Symptom relief
Last updated Jun 26, 2026 16:08 UTC
-
Question list may empower gynecologic cancer patients in clinic
Knowledge-focused CompletedThis study tests whether giving gynecologic cancer patients a list of questions to ask their doctor improves their confidence, reduces distress, and builds trust. About 70 adults with newly diagnosed or suspected gynecologic cancer will either receive the question list or usual c…
Sponsor: Ira Winer • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Embarrassment may be costing lives: study probes why women delay cancer checks
Knowledge-focused CompletedThis study interviewed 12 women diagnosed with gynaecological cancers (ovarian, womb, cervical, vulval, or vaginal) to understand what made them seek help or delay. Researchers focused on embarrassment and other barriers to early doctor visits. The goal is to use these insights t…
Sponsor: NHS Grampian • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New biomarker may predict which cancer drugs work best
Knowledge-focused CompletedThis completed study tested whether a new biomarker called 'mass response' can predict how well a cancer therapy will work. Researchers collected tumor cells from 72 patients with various cancers through fluid drainage or biopsies. The goal was to see if this biomarker could guid…
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New study sheds light on leg swelling after cancer surgery
Knowledge-focused CompletedThis study looked at 111 people who had surgery for early-stage cervical or vulvar cancer to find out how many develop lower leg swelling (lymphedema). Researchers used a questionnaire to gather information, not to test any new treatment. The goal is to better identify who is at …
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Simulation training teaches future nurses about vulvar cancer Self-Exams
Knowledge-focused CompletedThis study tested whether simulation-based training helps nursing students learn about vulvar cancer and how to perform self-exams. 94 students were randomly assigned to receive the training or not. Researchers measured changes in knowledge, skills, and attitudes toward clinical …
Sponsor: Trakya University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:09 UTC